Gastroenterology

Approval of Resmetirom marks a new milestone in the treatment of non-alcoholic steatohepatitis when used along with diet and exercise.

H. pylori infections can be safely and effectively managed with the Vonoprazan-amoxicillin combination along with Saccharomyc...

Facilitated telemedicine in opioid treatment programs boosts hepatitis C cure rates and cuts reinfections, offering favorable potential for elimi...

Deficiency of Vitamin D should be considered as a comorbidity in children with diarrhoea in developing countries, and focused...

Close monitoring of transaminase levels and adherence to a 30 mg per week dosage of Pegbelfermin maximizes treatment outcomes, emphasizing person...

Seladelpar proved to be a promising therapy for patients with primary biliary cholangitis, previously known as primary biliary cirrhosis.

Obeticholic acid (OCA) found effective in reducing liver test markers and improving nonalcoholic steatohepatitis-related fibrosis and inflammatio...

Patients with metabolic dysfunction-associated steatotic liver disease should not ignore the importance of personalized dietary interventions for...

Red flags can help guide clinicians toward a timely diagnosis of IBD in children with abdominal pain but there is a need for improved specificity...

Omeprazole provides rapid alleviation of symptoms (chest discomfort, acid reflux, etc.) by reducing their frequency and severity, and has a posit...

FDA-approved Linaclotide enhances bowel movement frequency and stool consistency, making it an effective therapy for treating constipation in chi...

For every 4 and 7 NAFLD patients, supplementation of Alpha-lipoic acid 1200 mg daily for 12 weeks, one achieves at least one and two grade i...